Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture
July 26, 2012
Newark, DE, USA and Chalfont St Giles, UK – iBio, Inc. (NYSE MKT: IBIO), and GE Healthcare, the healthcare business of GE (NYSE: GE), announced today a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines. The alliance builds on the existing development and marketing agreement between the two companies [...]
July 26, 2012
Drug development processes in the pharmaceutical industry are highly time- and cost intensive. The translation from in vitro to in vivo is affected by high failure rates of candidate compounds in pre-clinical and clinical phases. To mitigate this, there is an urgent need for more predictive in vitro models, capable of mimicking biological processes of [...]
Anton Paar GmbH and Polimate Ltda. form new sales organization in Brazil
July 26, 2012
The Austrian based company Anton Paar GmbH and its distributor in Brazil, Polimate Ltda., have decided to reorganize the distribution for Anton Paar products in Brazil as per January 1, 2013. The new company Anton Paar Brazil Ltda., with headquarters in Sao Paulo and offices in the most important regions of Brazil, will take over [...]
Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
July 25, 2012
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. Lung cancer is currently the leading cause of cancer deaths worldwide, claiming close to 1.5 [...]
Roche expands its blood screening portfolio
July 25, 2012
ROTKREUZ, Switzerland and PLEASANTON, Calif., -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it now offers an expanded portfolio of blood screening solutions with an integrated serology testing offering*. Roche is the global leader in the blood screening business based on its long-term success in nucleic acid testing (NAT). The addition of the [...]
Agilent Technologies Announces Favorable Legal Ruling from European Patent Office
July 25, 2012
Agilent Technologies Inc. (NYSE: A) today announced a favorable legal ruling from the European Patent Office regarding Agilent's opposition to patent EP 0853679, assigned to Affymetrix. On Oct. 21, 2003, Agilent joined Combimatrix and Clonediag in opposing the patent, titled "Expression Monitoring by Hybridization to High Density Oligonucleotide Arrays." Agilent opposed the breadth of the [...]
Picarro Secures $7 Million Round Of Investment From Leading Venture and Steategic Investors
July 25, 2012
Santa Clara, Calif. — Picarro Inc. today announced that it has secured a round of Series D equity financing led by Focus Ventures and joined by DAG Ventures, NTT Electronics and Mingxin China Growth Fund. The new round of investment will help Picarro expand its profile globally and within the commercial and industrial emissions sector [...]
July 25, 2012
Authentix, the global leaders in authentication, introduces the new Authentix MSX1000, a fuel test system that delivers forensic-level fuel analysis in a field-deployable format. Easy-to-use, ruggedized and transportable, the MSX1000 delivers a quick, robust field test to aid in the prevention of fuel adulteration, fuel smuggling, and fuel tax evasion. The MSX1000 system incorporates a [...]
July 25, 2012
INDIANAPOLIS, -- Roche Diabetes Care, makers of ACCU-CHEK® products and services, is pleased to announce the availability of the new, user-friendly ACCU-CHEK Nano SmartView System. The ACCU-CHEK Nano meter, part of the ACCU-CHEK Nano SmartView System, offers enhanced features including: ease-of-use, fast and accurate readings and small, portable size. Moreover, the meter offers patients the [...]
Molecular Devices Forms Scientific Advisory Board
July 25, 2012
Sunnyvale, CA, - Molecular Devices, LLC, today announced the formation of its Scientific Advisory Board (SAB). Comprising experts from a range of fields including stem cell research, biotherapeutics and cell signalling, the SAB will advise on strategy, product applications and product innovation, with the aim of identifying evolving customer needs and ensuring that the Molecular [...]
